Box score
NephroDI Therapeutics, Inc.
Reported $2M sold in a new Form D filed June 18, 2024 (Seattle, Washington).
- Biggest raise
- $2M filed Jun 18, 2024
- League
- Bio & Health Pharmaceuticals
- Based in
- Seattle, Washington
- Season rank
- #776 of 1,389 in the Bio & Health League; #5562 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-06-18 | New notice | $2M | $4M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1840655.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Aegis Impact & Innovation LLC rookie | Bio & Health | $3.4M |
| 2 | Big Bold Health Holdings, PBC | Bio & Health | $3M |
| 3 | Alpenglow Biosciences, Inc. | Bio & Health | $1.8M |
| 4 | Inmedix, Inc. | Bio & Health | $720K |
| 5 | Ora Biomedical, Inc. | Bio & Health | $720K |
| 6 | Hexamer Therapeutics, Inc | Bio & Health | $651K |